Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
April 8, 2026
Host Johnathan Miller interviews Board Director & CEO, Nancy Lurker, who shares some management information as well as some of their products insights.